Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Operating expenses        
Research and development $ 60,651 $ 459,957 $ 152,751 $ 595,316
General and administrative 670,276 1,022,078 1,958,329 2,107,058
Total operating expenses 730,927 1,482,035 2,111,080 2,702,374
Operating loss (730,927) (1,482,035) (2,111,080) (2,702,374)
Other expense (income)        
Change in fair value of warrant liability (26,437) (2,024,114) (38,998) (1,612,634)
Change in fair value of conversion rights of Series B preferred stock (3,326) (31,414) (88,532) 21,814
Net income (loss) before income taxes (701,164) 573,493 (1,983,550) (1,111,554)
Provision for income taxes 1,600 400 2,431 800
Net income (loss) (702,764) 573,093 (1,985,981) (1,112,354)
Less: Preferred deemed dividend     711,000  
Net income (loss) applicable to common shareholders $ (702,764) $ 573,093 $ (2,696,981) $ (1,112,354)
Basic earnings (loss) per common share (in dollars per share) $ (0.02) $ 0.03 $ (0.10) $ (0.06)
Diluted earnings (loss) per common share (in dollars per share) $ (0.02) $ 0.03 $ (0.10) $ (0.06)
Weighted average shares of common stock outstanding        
Basic (in shares) 28,376,141 19,913,163 25,814,315 19,909,042
Diluted (in shares) 28,376,141 20,135,645 25,814,315 19,909,042